Scepticism in press over Kintor’s COVID-19 US drug trial
pharmaphorum
MAY 14, 2021
Kintor posted a press release at the end of April to announce that phase 3 clinical development had begun and since then it has seen its share price rise considerably on the Hong Kong stock exchange. But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial.
52 
Let's personalize your content